Arab Finance: The Egyptian Exchange’s (EGX) listing committee has approved listing the issued and paid-up capital increase of the Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda), the EGX announced on September 6^th.

Accordingly, the issued and paid capital shall increase to EGP 380 million from EGP 252.113 million, with an increase of EGP 127.887 million.

This will be by issuing 511.549 million bonus shares, or 0.5225 bonus share for every share, at a par value of EGP 0.25 per share.

The eligibility in distribution will be for shareholders on a record date on September 20^th.

The company’s shares will be listed after the capital increase on the EGX's database with determining a reference price for its shares as of September 21st.

Cairo Housing’s OGM greenlights capital hike Updated 12/1/2025 10:02:00 AM

Rameda records 14.4% YoY consolidated profit hike in 9 months Updated 11/11/2025 10:55:00 AM

EGX approves Juhayna Food Industries capital increase to EGP 1.18B Updated 11/5/2025 9:46:00 AM

EFG Holding completes EGP 4.2B capital increase at Bank NXT Updated 11/3/2025 10:11:00 AM

B Investments Holding to maximize investment in medical subsidiary to EGP 250M Updated 10/14/2025 9:44:00 AM